| Patents for C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845) |
|---|
| 02/07/2013 | CA2843782A1 Anti-inflammatory steroids condensed in position 16,17 with pyrrolidine ring |
| 02/07/2013 | CA2843436A1 Novel 17.beta.-heteroaryl-substituted steroids as modulators of gaba a receptors |
| 01/31/2013 | WO2013016725A1 Progesterone antagonists |
| 01/31/2013 | WO2012123493A9 Isoxazolidine derivatives |
| 01/31/2013 | CA2846573A1 Progesterone antagonists |
| 01/30/2013 | CN102898499A Benzopyran triterpene, medicinal composition thereof and preparation method and application of benzopyran triterpene |
| 01/30/2013 | CN102898498A Specificity probe substrate of glucuronic acid transferase UGT1A3 and application of specificity probe substrate |
| 01/23/2013 | CN102887937A Cleaning production technology for obtaining saponin from dry sheets of Dioscorea zingiberensis |
| 01/22/2013 | US8357368 Methods of treating pancreatic or liver cancer using hedgehog antagonists |
| 01/16/2013 | CN102875638A Aspafilioside B preparation method |
| 01/16/2013 | CN102875637A Method for preparing pogosterol |
| 01/16/2013 | CN102875636A Method for preparing persicanidine A |
| 01/16/2013 | CN102875635A Method for comprehensively extracting protodioscin and dioscin from dioscorea nipponica |
| 01/16/2013 | CN102060906B Preparation method of R budesonide |
| 01/16/2013 | CN101830965B Method for catalyzing and hydrolyzing natural nucleoside compound by metal ion |
| 01/10/2013 | WO2012123493A3 Isoxazolidine derivatives |
| 01/09/2013 | EP2543380A1 Neural stem cells proliferation promoting agent |
| 01/09/2013 | EP2542085A1 Compounds useful for treating neurodegenerative disorders |
| 01/09/2013 | CN102866219A Method for extracting and detecting alpha-solanine in potato |
| 01/09/2013 | CN102863505A Process for synthesizing triamcinolone acetonide acetate |
| 01/09/2013 | CN102863504A Method for extracting trichilin B, trichilin D and trichilin H from melia |
| 01/09/2013 | CN102863503A Salaspermic acid purification method |
| 01/09/2013 | CN102863502A Method for extracting diosgenin from Trigonella foenum-graecum |
| 01/09/2013 | CN102863501A Spirostanol glycoside-type compound, and application and preparation method thereof |
| 01/09/2013 | CN102040643B Ciclesonide nitrate derivative |
| 01/02/2013 | CN102850426A A glucocorticoid with 21 site N-acetylcystein ester |
| 01/02/2013 | CN102050864B Transplanted wild ginseng ginsenoside B as well as extraction method and medical application thereof |
| 01/02/2013 | CN101948503B Method for preparing betamethasone ketal by homogeneous reaction at normal temperature |
| 01/02/2013 | CN101885752B Method for converting and synthesizing saponin through adventitious root system culture of Chinese thorowax root |
| 12/26/2012 | CN102391353B Walsuralactam A and preparation method and application in medicament thereof |
| 12/19/2012 | CN102834406A Novel [3.2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof |
| 12/19/2012 | CN102827243A Method for purifying sakura saponins |
| 12/18/2012 | CA2519956C Compound |
| 12/13/2012 | WO2012170573A2 New taccalonolide microtubule stabilizers |
| 12/13/2012 | CA2838401A1 New taccalonolide microtubule stabilizers |
| 12/12/2012 | EP2531516A2 Pregnane compounds condensed in position 16,17 with a pyrolidine ring with glucocorticoid activity |
| 12/06/2012 | US20120309959 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 12/05/2012 | CN102311481B Methyl toonapubesate A and preparation method as well as application thereof |
| 12/05/2012 | CN102295679B Sesterterpene compound and purpose thereof |
| 12/04/2012 | CA2562189C Azacyclosteroid histamine-3 receptor ligands |
| 11/28/2012 | CN102803285A Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound |
| 11/28/2012 | CN102796160A 17ss-hsd1 and sts inhibitors |
| 11/28/2012 | CN102329368B 20 alpha,22 beta,23 alpha-trihydroxy steroidal compound, and synthesis method and application thereof |
| 11/28/2012 | CN102153611B Method for synthesizing pregnenolol acetate and congener thereof |
| 11/28/2012 | CN101768203B 5beta, 6beta epoxy steroidal compound and preparation method thereof |
| 11/27/2012 | CA2597300C Novel betulinic acid derivatives |
| 11/22/2012 | WO2012157130A1 Method for differentiating adenoma of primary aldosteronism and method for determining 18-oxocortisol (18-oxof) and 18-hydroxycortisol (18-ohf) |
| 11/21/2012 | CN102786575A Diosgenin-3-derivative as well preparation method and application thereof |
| 11/21/2012 | CN101717428B Method for synthesizing budesonide |
| 11/15/2012 | US20120289471 Novel compounds with high therapeutic index |
| 11/14/2012 | CN102775464A Method for washing turmeric saponin acid hydrolysate |
| 11/14/2012 | CN102268062B Process for clean production of saponin by utilizing turmeric |
| 11/14/2012 | CN102180941B Derivatives of betulonic acid, method for preparing same and application thereof |
| 11/14/2012 | CN102167720B Betulonic acid derivant for restraining differentiation of osteoclast, preparation method thereof and application thereof |
| 11/14/2012 | CN102020694B Method for synthesizing 16beta,21-epoxy-20S-methyl-alkene-3beta,21beta-pregnane-diol |
| 11/14/2012 | CN101255184B Hepatitis B resistant compound, medicament composition and use in medicament preparation |
| 11/08/2012 | US20120283450 Compounds including an anti-inflammatory pharmacore and methods of use |
| 11/07/2012 | CN102372762B Novel technology for synthesizing pregnene 11-site beta-hydroxy |
| 11/07/2012 | CN102219825B Method for synthesizing 3beta-hydroxy-16alpha,17alpha-epoxy-5-pregnene-20-ketone |
| 10/31/2012 | CN102757473A Concentration method of yam saponin slurry before acidolysis |
| 10/26/2012 | WO2012096934A3 Inhibitors of retroviral replication |
| 10/25/2012 | US20120270836 Therapeutic approaches for treating alzheimer's disease |
| 10/24/2012 | CN102746370A Novel technology for oxosynthesis of pregnane 11-bit ketonic group |
| 10/24/2012 | CN102746369A Novel technology for synthesizing pregnane 21-bit iodide by nitrite |
| 10/24/2012 | CN102746367A Novel technology for synthesis of pregnane 21-bit chloride |
| 10/24/2012 | CN102746358A Novel technology for synthesis of pregnane 21-bit bromide |
| 10/24/2012 | CN102746357A Technology for synthesizing reduced steroid |
| 10/24/2012 | CN102743352A Triamcinolone tablet and polymorphs and preparation method |
| 10/23/2012 | CA2706180C Novel glucocorticoid receptor agonists |
| 10/17/2012 | CN102741268A Pyrrolidine derivatives |
| 10/17/2012 | CN102731610A 26-thio or -seleno spirostanol saponin, synthesis method and application thereof |
| 10/17/2012 | CN102731609A Method for efficiently synthesizing solamargine |
| 10/17/2012 | CN102731608A Preparation method of tea saponin ester succinate surfactant and product thereof |
| 10/17/2012 | CN102727501A Uses of sapogenins and their derivatives |
| 10/17/2012 | CN102167719B Method for separating and preparing steroidal saponins from garlic by utilizing high speed countercurrent chromatography |
| 10/16/2012 | CA2485794C Triptolide derivatives for modulation of apoptosis and immunosuppression |
| 10/11/2012 | US20120258923 BIOACTIVITY COMPOSITION OF Reevesia formosana |
| 10/10/2012 | CN102276683B Smilaxchinoside compound |
| 10/10/2012 | CN102060905B Technology method for preparing sea cucumber saponin Holotoxin A1 comparison product by utilizing fresh sea cucumber processing waste liquid |
| 10/04/2012 | US20120252772 Cucurbitane-Triterpenoid Compounds, Pharmaceutical Composition, Use and Preparation Method Thereof |
| 10/03/2012 | CN102702301A Novel process for extracting diosgenin |
| 10/03/2012 | CN102702300A Compound for preventing or treating autoimmune diabetes and preparation method and application thereof |
| 10/03/2012 | CN102702298A Glycyrrhetinic acid derivative and preparation method and medical application thereof |
| 10/03/2012 | CN102212102B Method for extracting sisal hemp cream from sisal hemp slag water |
| 09/26/2012 | EP2502931A1 Inhibitor of dopa oxidase activity and skin lightening agent |
| 09/26/2012 | EP2501710A2 Process for preparing (11beta, 16alpha)-9-fluoro-11-hydroxy-16,17-[1-methyl-ethylidenebis(oxy)]-21-[1-oxo-[4-(nitrooxymethyl)benzoxy]]pregna-1,4-dien-3,20-dione |
| 09/20/2012 | WO2012123493A2 Isoxazolidine derivatives |
| 09/20/2012 | WO2012123482A2 Isoxazolidine derivatives |
| 09/20/2012 | US20120238531 Isoxazolidine derivatives |
| 09/20/2012 | US20120234316 Isoxazolidine derivatives |
| 09/20/2012 | CA2850081A1 Isoxazolidine derivatives |
| 09/20/2012 | CA2829982A1 Isoxazolidine derivatives |
| 09/19/2012 | CN102675403A Synthesis of anti-hepatitis B medicine LQC-X and application thereof |
| 09/19/2012 | CN102030814B Method for preparing high purity 9,11-dehydromanogenin |
| 09/12/2012 | CN102666564A Dopa oxidase activity inhibitor and skin whitening agent |
| 09/12/2012 | CN102659911A Method for extracting diosgenin from turmeric |
| 09/12/2012 | CN102659910A High-efficiency extraction and cleaning production process for diosgenin |
| 09/12/2012 | CN102659909A Method for separating dioscin hydrolysate |
| 09/12/2012 | CN102659908A Method for extracting and separating agapanthussaponin A |
| 09/12/2012 | CN102659907A Method for extracting chloromaloside A |